Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases

被引:44
作者
Wang, Xiao-Lei [1 ]
Fang, Jian-Ping [2 ]
Tang, Ru-Yong [2 ]
Chen, Xi-Mei [1 ]
机构
[1] Tongji Univ, Dept Gastroenterol, Inst Digest Dis, Tongji Hosp, Shanghai 200065, Peoples R China
[2] Tongji Univ, Dept Pathol, Tongji Hosp, Shanghai 200065, Peoples R China
关键词
MONOCLONAL-ANTIBODY D2-40; SQUAMOUS-CELL CARCINOMAS; GROWTH-FACTOR-C; NODE METASTASIS; VEGF-C; TUMOR LYMPHANGIOGENESIS; FACTOR-A; INVASION; ANGIOGENESIS; EXPRESSION;
D O I
10.1186/1471-2407-10-299
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Patients with gastric cancer in China have worse outcome and poorer prognosis. Tumor-induced lymphangiogenesis plays a crucial role in metastasis and tumor progression. The intratumoral and peritumoral lymphatics were supposed to have different biological effects. Three major growth factors, vascular endothelial growth factor- (VEGF)-A, VEGF-C and VEGF-D, are involved in the activation process via their receptors (VEGFRs). The purpose of current study is to investigate the significant difference between intratumoral and peritumoral lymphatic vessel density (LVD) in gastric cancer and their correlations with lymphangiogenetic growth factors. Methods: Intratumoral LVD (I-LVD) and peritumoral LVD (P-LVD) of 123 patients with primary gastric cancer were assessed after staining with D2-40, and confirmed by double staining with D2-40/CD34. Proliferative activity of lymphatics endothelium was evaluated by double staining with D2-40/Ki-67. The associations were analyzed between I-LVD/P-LVD and the expression level of VEGF-A, VEGF-C, VEGF-D and the receptor VEGFR-3, which was measured by immunohistochemistry (IHC). The correlations of I-LVD and P-LVD with patient prognosis were also valued. Results: (1) The peritumoral lymphatics (PTLs) were relatively enlarged with dilated lumen compared with the intratumoral lymphatics (ITLs). Increased P-LVD was significantly higher than I-LVD (P < 0.05). (2) P-LVD was found significantly associated with lymph node metastasis (LNM) (P < 0.001), lymphatic vessel invasion (LVI) (P < 0.001), VEGF-C (P = 0.003), VEGF-D expression level (P = 0.005) and VEGFR-3 expression level (P < 0.001) in peritumoral tissues, despite no significant association was found between above variants with I-LVD. However, increased I-LVD was demonstrated to be associated with decreased tumor volume (P < 0.001). Neither I-LVD nor P-LVD was correlated with VEGF-A expression (P > 0.05). (3) Proliferative activity of lymphatics endothelium was observed in PTLs, in spite of ITLs. (4) Increased P-LVD, but not I-LVD, was indicated to be an independent risk factor for lymph node metastasis by multivariate logistic regression analysis, and was related to worse disease-free survival and overall survival. Conclusions: PTLs play roles in gastric cancer progression. Increased P-LVD, but not I-LVD, was significantly associated with VEGF-C/-D/VEGFR-3 system, and could be an independent risk factor for lymph node metastasis and a prognostic factor in gastric cancer.
引用
收藏
页数:11
相关论文
共 33 条
[31]   Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases [J].
Zhang, Yanzhi ;
Dai, Jiali ;
McNamara, Keely M. ;
Bai, Bing ;
Shi, Mumu ;
Chan, Monica S. M. ;
Liu, Ming ;
Sasano, Hironobu ;
Wang, Xiuli ;
Li, Xiaolei ;
Liu, Lijuan ;
Ma, Ying ;
Cao, Shuwen ;
Xing, Yanchun ;
Zhao, Baoshan ;
Song, Yinli ;
Wang, Lin .
BMC CANCER, 2015, 15
[32]   The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study [J].
Jia, Yong-Xu ;
Li, Teng-Fei ;
Zhang, Dan-Dan ;
Fan, Zong-Min ;
Fan, Hui-Jie ;
Yan, Jie ;
Chen, Li-Juan ;
Tang, Hong ;
Qin, Yan-Ru ;
Li, Xing-Ya .
ONCOTARGETS AND THERAPY, 2016, 9 :5919-5929
[33]   A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer [J].
Park, Jae Kil ;
Kim, Jae Jun ;
Moon, Seok Whan .
JOURNAL OF THORACIC DISEASE, 2016, 8 (05) :784-794